resTORbio Announces Delay of its Ongoing Phase 1b/2a trial of RTB101 in Patients with Parkinson’s Disease Due to COVID-19 Level 4 Alert in New Zealand
BOSTON, April 03, 2020 (GLOBE NEWSWIRE) — resTORbio (Nasdaq: TORC) today announced that it will postpone enrollment in the fifth […]